U.S. Markets close in 3 hrs 19 mins

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real Time Price. Currency in USD
155.22+0.52 (+0.34%)
As of 12:41PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close154.70
Bid0.00 x 800
Ask0.00 x 800
Day's Range154.53 - 155.86
52 Week Range95.02 - 155.86
Avg. Volume1,441,591
Market Cap348.992B
Beta (5Y Monthly)0.33
PE Ratio (TTM)53.16
EPS (TTM)2.92
Earnings DateN/A
Forward Dividend & Yield1.77 (1.27%)
Ex-Dividend DateMar 24, 2023
1y Target Est140.39
  • Zacks

    Novo Nordisk (NVO) Meets Semaglutide Higher Dosage Study Goal

    Novo Nordisk (NVO) announces positive top-line results from its phase III increased dosage study of semaglutide, 25 mg and 50 mg, for the treatment of patients with type II diabetes.

  • GlobeNewswire

    Novo Nordisk A/S - share repurchase programme

    Bagsværd, Denmark, 27 March 2023 – On 1 February 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 28 billion to be executed during a 12-month period beginning 1 February 2023. Under the programme i

  • Zacks

    Here's How Much You'd Have If You Invested $1000 in Novo Nordisk a Decade Ago

    Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.